- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03049241
Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults (LENGTH-FATIG)
Potential factors involved in neuromuscular fatigue were classified into two categories: 1) central factors involving the central nervous system and neural pathways, and 2) peripheral factors occurring within the muscle beyond the neuromuscular junction. In adults, it has been shown that peripheral factors contribute to a large part of the fatigue induced by repeated maximal contractions. However in children, central factors could account for the development of fatigue to a greater extent. Force-generating capacity and musculotendinous stiffness could be two of the discriminatory factors accounting for the differences in the neuromuscular fatigue between children and adults.
Force production capacity and musculotendinous stiffness vary as function of muscle length. Naturally, they could differ depending on the muscle groups studied. The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults. The investigators formulated the hypotheses that at short muscle length force and low musculotendinous stiffness, differences in force between children and adults would be reduced. Thus neuromuscular fatigue development and aetiology would be similar between both groups. The results of the present protocol will allow to better understanding of the aetiology of neuromuscular fatigue in children and help improving training or rehabilitation programs.
Přehled studie
Detailní popis
The study of neuromuscular fatigue in children is a recently topic in the field of sport sciences. Such knowledge could improve the efficiency and security of training and rehabilitation in healthy children and children with diseases like obesity.
The LENGTH-FATIG study will provide knowledge about the peripheral and central mechanisms of the neuromuscular fatigue in children and adults. Fatigue will test for different muscle groups (knee extensors and ankle plantar flexors) at different muscle lengths (short, optimal and long).
During high-intensity exercise, prepubertal children are more resistant to fatigue than adults. Contributions of the central and peripheral components to the development of neuromuscular fatigue are also different between both populations. The reduced children's fatigue coud be particularly related to a lower peripheral (i.e. muscular) fatigue. This might be attributed to the fact that prepubertal children rely more on oxidative than anaerobic metabolism than adults during fatiguing exercise. On the other hand, nervous factors could also explain differences in fatigue between children and adults. However, this topic is scarcely documented and still controversial. To our knowledge, no study has still compared the aetiology of central fatigue (supra-spinal vs. spinal) between children and adults. Only the voluntary activation level had been studied in children, conventionally used to assess central fatigue. But this factor doesn't differentiate spinal and supra-spinal contributions to neuromuscular fatigue development.
The LENGTH-FATIG research project is a physiological and observational study comparing two age groups (adults and children). Subjects will have to perform three randomized fatigue protocols at three muscle lengths (short, optimal and long) with the knee extensors and the ankle plantar flexors.
Data will be analyzed using LabChart 7.3 Pro software (ADInstrument, New South Wales, Australia) and Statistica 8.0 software (StatSoft, Inc.) and significance will be accepted at a two-sided alpha level of p<.05. The normality and homogeneity of the variables will be checked respectively from a Shapiro-Wilk test and a Barlett test.
If normality and homogeneity of the variables are verified, absolute values of variables (Force, EMG, NIRS, etc.) will be compared using three factors (age x muscle length x muscle group) analyses of variance (ANOVA) with repeated measures. If analyses reveal a significant effect of any factor or interaction of factors, post-hoc Newman-Keuls tests will be performed to determine differences between the different conditions.
If, on the contrary, normality and homogeneity of the variables are not verified, the effects of muscle length, muscle group and age will be evaluated using a Friedman test. If the tests show significant effects, comparisons of the different conditions will be performed using Mann-Whitney and Wilcoxon tests.
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
-
Clermont-Ferrand, Francie, 63003
- CHU clermont-ferrand
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Boys aged 8 to 11 years old, Tanner stages 1 to 3
- Male aged 18 to 35 years old
- Non-smoker
- Moderate physical activity level (< 4h/week)
- Covered by a social health insurance
- Consent form signed by participants and/or legal guardians.
Exclusion Criteria:
- Competitive training
- Cardiac or pulmonary diseases
- Epileptic seizures past history
- Magnetic field contraindication (including cardiac valve, pacemaker, prosthesis material, ferro-magnetic foreign body, cochlear implant and ocular prosthesis material.
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
---|---|
knee extensors
|
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults
|
ankle plantar
|
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Časové okno |
---|---|
Maximal torque of knee extensors
Časové okno: once a week during six weeks.
|
once a week during six weeks.
|
ankle plantar flexors joint (in N.m) measured with a dynamometer.
Časové okno: once a week during six weeks.
|
once a week during six weeks.
|
Sekundární výstupní opatření
Měření výsledku |
Časové okno |
---|---|
Doublet torque amplitude (100Hz, in N.m) evoked using magnetic nerve stimulation at rest
Časové okno: once a week during six weeks.
|
once a week during six weeks.
|
Muscular tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy.
Časové okno: once a week during six weeks
|
once a week during six weeks
|
Compound muscle action potential amplitude (i.e. M-wave ; in mV) evoked by supramaximal magnetic nerve stimulation and measured by surface Electromyography (EMG).
Časové okno: once a week during six weeks
|
once a week during six weeks
|
High frequency doublet (100Hz)/low frequency doublet (10Hz) ratio
Časové okno: once a week during six weeks
|
once a week during six weeks
|
fascicule length (mm) measured by B-mode real time ultrasound scanner.
Časové okno: once a week during six weeks
|
once a week during six weeks
|
pennation angle (degree) measured by B-mode real time ultrasound scanner.
Časové okno: once a week during six weeks
|
once a week during six weeks
|
Voluntary activation level (in %) assessed by using the twitch interpolation technique.
Časové okno: once a week during six weeks
|
once a week during six weeks
|
EMG signal Root mean square of EMG signal during isometric maximal voluntary contractions.
Časové okno: once a week during six weeks
|
once a week during six weeks
|
Hoffman reflex amplitude (i.e. H-reflex ; in mV) evoked by submaximal magnetic nerve stimulation measured by surface Electromyography (EMG).
Časové okno: once a week during six weeks
|
once a week during six weeks
|
Cerebral tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy
Časové okno: once a week during six weeks
|
once a week during six weeks
|
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- CHU-304
- 2016-A00827-44 (Jiný identifikátor: 2016-A00827-44)
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .